SCM
FENC icon

Solas Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.5M Sell
2,232,902
-18,017
-0.8% -$150K 10.37% 2
2025
Q1
$13.7M Hold
2,250,919
7.71% 4
2024
Q4
$14.2M Buy
2,250,919
+327,383
+17% +$2.07M 9.45% 2
2024
Q3
$9.62M Buy
1,923,536
+583,536
+44% +$2.92M 6.75% 7
2024
Q2
$8.19M Buy
1,340,000
+229,767
+21% +$1.4M 4.48% 11
2024
Q1
$12.3M Sell
1,110,233
-268,280
-19% -$2.98M 7.94% 5
2023
Q4
$15.5M Sell
1,378,513
-347,054
-20% -$3.89M 9.6% 2
2023
Q3
$13M Buy
1,725,567
+286,539
+20% +$2.15M 9.07% 3
2023
Q2
$12.7M Buy
1,439,028
+154,485
+12% +$1.36M 8.45% 2
2023
Q1
$10.7M Buy
1,284,543
+32,155
+3% +$268K 5.71% 7
2022
Q4
$12M Buy
1,252,388
+121,221
+11% +$1.16M 7.21% 4
2022
Q3
$9.16M Sell
1,131,167
-42,349
-4% -$343K 5.59% 5
2022
Q2
$6.55M Buy
1,173,516
+27,720
+2% +$155K 3.91% 11
2022
Q1
$6.42M Buy
1,145,796
+277,939
+32% +$1.56M 3.89% 12
2021
Q4
$3.82M Hold
867,857
2.72% 17
2021
Q3
$8.18M Hold
867,857
5.69% 5
2021
Q2
$6.33M Buy
867,857
+67,857
+8% +$495K 4.44% 9
2021
Q1
$4.97M Hold
800,000
4.18% 9
2020
Q4
$5.96M Hold
800,000
4.55% 9
2020
Q3
$4.85M Sell
800,000
-160,000
-17% -$970K 4.64% 8
2020
Q2
$8.02M Hold
960,000
7.4% 3
2020
Q1
$5.7M Sell
960,000
-11,795
-1% -$70.1K 6.17% 5
2019
Q4
$6.31M Buy
971,795
+28,595
+3% +$186K 6.06% 6
2019
Q3
$4.54M Buy
943,200
+93,221
+11% +$448K 4.69% 10
2019
Q2
$3.4M Buy
+849,979
New +$3.4M 3.47% 12